Key result
Dietary capsaicin is linked to lower hypertension risk, highlighting the therapeutic potential of TRPV1-targeting drugs.
Why the study?
Hypertension is increasing due to modern sedentary lifestyles, and new treatments are needed given evidence suggesting TRPV1 activation may regulate blood pressure.
Do TRPV1-targeting drugs (capsaicin) reduce blood pressure in hypertensive patients?
Do TRPV1-targeting drugs (capsaicin) reduce blood pressure in hypertensive patients?
TRPV1 activation by capsaicin represents a potential novel therapeutic target for blood pressure reduction in hypertension.
Hypothesis-generating for TRPV1 agonists in hypertension; should not change practice without randomized confirmation.
Today's sedentary lifestyle with excess food and little exercise increases the number of people with hypertension, a major risk factor for stroke. New knowledge of treatments in this field is of utmost importance. In animal experiments, the activation by capsaicin of TRPV1-expressing sensory afferents evokes a drop in blood pressure by triggering the Bezold-Jarisch reflex. In hypertensive rats, capsaicin reduces blood pressure. Conversely, genetic ablation of the TRPV1 receptor results in elevated nocturnal (but not diurnal) blood pressure. These observations imply a therapeutic potential for TRPV1 activation in hypertensive patients. Indeed, in a major epidemiological study involving 9273 volunteers, dietary capsaicin was found to lower the risk for hypertension. New research indicates that the mechanism of action of capsaicin on blood pressure regulation is far more complex than previously thought. In addition to the well-recognized role of capsaicin-sensitive afferents in blood pressure regulation, TRPV1 seems to be expressed both in endothelial cells and vascular smooth muscle. This review aims to evaluate the therapeutic potential of TRPV1-targeting drugs in hypertensive patients.
No takes yet. Share an insight, caveat, or question.
A Szállaśi (2023) conducted a review in Hypertension. TRPV1-targeting drugs (Capsaicin) was evaluated. Dietary capsaicin was found to lower the risk for hypertension in an epidemiological study of 9273 volunteers, highlighting the therapeutic potential of TRPV1-targeting drugs.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: